Eventually, individuals on tirzepatide had a low occurrence of end-stage kidney disease, death due to kidney failure, macroalbuminuria, and eGFR decline compared to individuals on insulin glargine [14]
JCI Insight 4 , e128863 (2019)
State medical boards will hold you to the same expectations as any physician treating obesity
Evidence Quality Summary The honest assessment: mechanistic data is compelling, animal data is supportive, and human data exists but is not conclusive for GHK-Cu alone
The cheapest option is not necessarily the best value if the medication arrives late, lacks potency, or comes from a pharmacy with questionable quality controls
however, magnetic resonance brain showed no evidence of infarction or bleeding